Advertisement
Journal Home
Search for

Volume 155, Issue 5, Pages 714-720 (November 2009)


View previous. 36 of 62 View next.

Effects of Treatment with Oxandrolone for 4 Years on the Frequency of Severe Arithmetic Learning Disability in Girls with Turner Syndrome

Judith L. Ross, MDabCorresponding Author Informationemail address, Michele M.M. Mazzocco, PhDc, Harvey Kushner, PhDd, Karen Kowal, PAa, Gordon B. Cutler Jr., MDe, David Roeltgen, MDf

Received 13 November 2008; received in revised form 14 April 2009; accepted 21 May 2009. published online 30 July 2009.

Objectives

To study androgen treatment effects on arithmetic performance in girls with Turner syndrome.

Study design

Forty-four girls, ages 10 to 14 years at baseline, completed 4 years of treatment with oxandrolone (Ox) or placebo (Pl). All received growth hormone and estrogen replacement therapy. We assessed the number of girls with severe learning disability (LD, standard score ≤5th percentile) on measures of academic arithmetic and reading achievement (WRAT-3, arithmetic and reading), given yearly, and the WIAT numerical operations (NOS) and reading subtests, given at year 4.

Results

On the WRAT-3 arithmetic, the frequency of severe arithmetic LD was similar in the Ox and Pl groups at baseline and at years 1 and 2. At years 3 and 4, fewer girls in the Ox than Pl group had a severe arithmetic LD (year 4: 0/22 vs 5/21, P = .02). On the WIAT NOS (year 4), fewer girls in the Ox than Pl groups had a severe arithmetic LD (3/21 vs 8/20, P = .09). WIAT NOS error analysis suggested that the improved performance in the Ox group was associated with better performance on multiplication and division (P < .01). The frequency of severe LD for the WRAT-3 reading was similar for the Ox and Pl groups (all years) and for the WIAT reading subtest (year 4).

Conclusions

Androgen treatment for 4 years in girls with Turner syndrome resulted in a small decrease in frequency of severe arithmetic LD, with no effect on reading LD.

a Thomas Jefferson University, Philadelphia, PA

b Department of Pediatrics and the duPont Hospital for Children, Wilmington, DE

c Kennedy Krieger Institute, Johns Hopkins University, Baltimore, MD

d Biomedical Computer Research Institute, Philadelphia, PA

e Developmental Endocrinology Branch, NICHD, NIH, Bethesda, MD

f Department of Neurology and Center for Aphasia Research and Rehabilitation, Georgetown University, Washington, DC

Corresponding Author InformationReprint requests: Dr Judith L. Ross, Thomas Jefferson University, Department of Pediatrics, Suite 726, 1025 Walnut Street, Philadelphia, PA 19107.

 Supported by NIH NS32531. The authors declare no conflicts of interest.

PII: S0022-3476(09)00538-1

doi:10.1016/j.jpeds.2009.05.031


View previous. 36 of 62 View next.

Advertisement